Cite
HARVARD Citation
Walkden, A. et al. (2020). Atypical Ocular Toxoplasmosis During Adalimumab Anti–Tumor Necrosis Factor Therapy for Rheumatoid Arthritis. Journal of clinical rheumatology. 26 (8), p. . [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Walkden, A. et al. (2020). Atypical Ocular Toxoplasmosis During Adalimumab Anti–Tumor Necrosis Factor Therapy for Rheumatoid Arthritis. Journal of clinical rheumatology. 26 (8), p. . [Online].